![](https://nthumb.tpgimages.com/mid2_com_img/1339/31450/TOP29699228.jpg)
Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, a process that is being developed to treat cancer. T cells (shown in cross-section), part of the bodyIllustrations immune system, are taken from the patient and have their DNA (deoxyribonucleic acid) modified by viruses (round) so that they produce chimeric antigen receptor (CAR) proteins (blue). These proteins will be specific to the patientIllustrations cancer. They have an extracellular receptor component and an internal signalling and co-stimulatory domain. The modified T cells are then multiplied in the laboratory before being reintroduced to the patient.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP29699228
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images: